These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 33201987

  • 1. Proscillaridin A inhibits hepatocellular carcinoma progression through inducing mitochondrial damage and autophagy.
    Luo M, Liu Y, Liu N, Shao W, Ming L, Liu J, Xie Y.
    Acta Biochim Biophys Sin (Shanghai); 2021 Jan 12; 53(1):19-28. PubMed ID: 33201987
    [Abstract] [Full Text] [Related]

  • 2. Thiostrepton as a Potential Therapeutic Agent for Hepatocellular Carcinoma.
    Su G, Yang Q, Zhou H, Huang Y, Nie S, Wang D, Ma G, Zhang S, Kong L, Zou C, Li Y.
    Int J Mol Sci; 2024 Sep 08; 25(17):. PubMed ID: 39273665
    [Abstract] [Full Text] [Related]

  • 3. ONC206 targeting ClpP induces mitochondrial dysfunction and protective autophagy in hepatocellular carcinoma cells.
    Cao J, Cao F, Wang C, Jiao Z, You Y, Wang X, Zhao W.
    Neoplasia; 2024 Sep 08; 55():101015. PubMed ID: 38944913
    [Abstract] [Full Text] [Related]

  • 4. Targeted degradation of NDUFS1 by agrimol B promotes mitochondrial ROS accumulation and cytotoxic autophagy arrest in hepatocellular carcinoma.
    Dong L, Luo L, Wang Z, Lian S, Wang M, Wu X, Fan J, Zeng Y, Li S, Lv S, Yang Y, Chen R, Shen E, Yang W, Li C, Wang K.
    Free Radic Biol Med; 2024 Aug 01; 220():111-124. PubMed ID: 38697493
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Proscillaridin A exerts anti-tumor effects through GSK3β activation and alteration of microtubule dynamics in glioblastoma.
    Berges R, Denicolai E, Tchoghandjian A, Baeza-Kallee N, Honore S, Figarella-Branger D, Braguer D.
    Cell Death Dis; 2018 Sep 24; 9(10):984. PubMed ID: 30250248
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of mitochondrial respiration overcomes hepatocellular carcinoma chemoresistance.
    Sun Y, Xu H, Chen X, Li X, Luo B.
    Biochem Biophys Res Commun; 2019 Jan 08; 508(2):626-632. PubMed ID: 30522865
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of autophagic flux by salinomycin results in anti-cancer effect in hepatocellular carcinoma cells.
    Klose J, Stankov MV, Kleine M, Ramackers W, Panayotova-Dimitrova D, Jäger MD, Klempnauer J, Winkler M, Bektas H, Behrens GM, Vondran FW.
    PLoS One; 2014 Jan 08; 9(5):e95970. PubMed ID: 24816744
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Novel lysophosphatidic acid receptor 6 antagonists inhibit hepatocellular carcinoma growth through affecting mitochondrial function.
    Gnocchi D, Kapoor S, Nitti P, Cavalluzzi MM, Lentini G, Denora N, Sabbà C, Mazzocca A.
    J Mol Med (Berl); 2020 Feb 08; 98(2):179-191. PubMed ID: 31863151
    [Abstract] [Full Text] [Related]

  • 12. DMAMCL exerts antitumor effects on hepatocellular carcinoma both in vitro and in vivo.
    Yao S, Ye J, Yin M, Yu R.
    Cancer Lett; 2020 Jul 28; 483():87-97. PubMed ID: 32268165
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of autophagy enhances anticancer effects of bevacizumab in hepatocarcinoma.
    Guo XL, Li D, Sun K, Wang J, Liu Y, Song JR, Zhao QD, Zhang SS, Deng WJ, Zhao X, Wu MC, Wei LX.
    J Mol Med (Berl); 2013 Apr 28; 91(4):473-83. PubMed ID: 23052483
    [Abstract] [Full Text] [Related]

  • 14. Targeting autophagy potentiates chemotherapy-induced apoptosis and proliferation inhibition in hepatocarcinoma cells.
    Guo XL, Li D, Hu F, Song JR, Zhang SS, Deng WJ, Sun K, Zhao QD, Xie XQ, Song YJ, Wu MC, Wei LX.
    Cancer Lett; 2012 Jul 28; 320(2):171-9. PubMed ID: 22406827
    [Abstract] [Full Text] [Related]

  • 15. Autophagy activation in hepatocellular carcinoma contributes to the tolerance of oxaliplatin via reactive oxygen species modulation.
    Ding ZB, Hui B, Shi YH, Zhou J, Peng YF, Gu CY, Yang H, Shi GM, Ke AW, Wang XY, Song K, Dai Z, Shen YH, Fan J.
    Clin Cancer Res; 2011 Oct 01; 17(19):6229-38. PubMed ID: 21825039
    [Abstract] [Full Text] [Related]

  • 16. Long non-coding RNA TPTEP1 inhibits hepatocellular carcinoma progression by suppressing STAT3 phosphorylation.
    Ding H, Liu J, Zou R, Cheng P, Su Y.
    J Exp Clin Cancer Res; 2019 May 09; 38(1):189. PubMed ID: 31072375
    [Abstract] [Full Text] [Related]

  • 17. Propyl gallate inhibits hepatocellular carcinoma cell growth through the induction of ROS and the activation of autophagy.
    Wei PL, Huang CY, Chang YJ.
    PLoS One; 2019 May 09; 14(1):e0210513. PubMed ID: 30653551
    [Abstract] [Full Text] [Related]

  • 18. Betulinic acid induces apoptosis and suppresses metastasis in hepatocellular carcinoma cell lines in vitro and in vivo.
    Wang W, Wang Y, Liu M, Zhang Y, Yang T, Li D, Huang Y, Li Q, Bai G, Shi L.
    J Cell Mol Med; 2019 Jan 09; 23(1):586-595. PubMed ID: 30417527
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of autophagy potentiates the antitumor effect of the multikinase inhibitor sorafenib in hepatocellular carcinoma.
    Shimizu S, Takehara T, Hikita H, Kodama T, Tsunematsu H, Miyagi T, Hosui A, Ishida H, Tatsumi T, Kanto T, Hiramatsu N, Fujita N, Yoshimori T, Hayashi N.
    Int J Cancer; 2012 Aug 01; 131(3):548-57. PubMed ID: 21858812
    [Abstract] [Full Text] [Related]

  • 20. W436, a novel SMART derivative, exhibits anti-hepatocarcinoma activity by inducing apoptosis and G2/M cell cycle arrest in vitro and in vivo and induces protective autophagy.
    Man S, Wu Z, Sun R, Guan Q, Li Z, Zuo D, Zhang W, Wu Y.
    J Biochem Mol Toxicol; 2021 Aug 01; 35(8):e22831. PubMed ID: 34155709
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.